w66最给利老牌
w66最给利老牌:About Us
w66最给利老牌:About Sino Biopharm
w66最给利老牌:Board of Directors
w66最给利老牌:Senior Management
w66最给利老牌:R&D
R&D Team
w66最给利老牌:Products
Product List
w66最给利老牌:Sustainability
w66最给利老牌:ESG Governance
ESG Management Practices
w66最给利老牌:ESG Reports
w66最给利老牌:Investors
w66最给利老牌:Information Disclosure
w66最给利老牌:Corporate Governance
w66最给利老牌:Presentation
w66最给利老牌:Investor FAQ
Notices
w66最给利老牌:News
w66最给利老牌:Press Releases
Contact
CN
EN
Investors
Home
>
w66最给利老牌:Investors
>
Information Disclosure
w66最给利老牌:
Information Disclosure
w66最给利老牌:
Corporate Governance
w66最给利老牌:
Presentation
w66最给利老牌:
Investor FAQ
w66最给利老牌:
Notices
Information Disclosure
Annual Report
2005.04.14
Interim Report
2004.09.02
Annual Report
2004.04.06
Annual Report 2002
2003.03.18
Annual Report 2001
2002.03.14
Annual Report 2000
2001.03.19
首页
上一页
47
48
49
50
51
52